172 related articles for article (PubMed ID: 15379908)
1. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.
Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J
J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908
[TBL] [Abstract][Full Text] [Related]
2. The effect of vitamin C supplementation in healthy dogs on antioxidative capacity and immune parameters.
Hesta M; Ottermans C; Krammer-Lukas S; Zentek J; Hellweg P; Buyse J; Janssens GP
J Anim Physiol Anim Nutr (Berl); 2009 Feb; 93(1):26-34. PubMed ID: 19386005
[TBL] [Abstract][Full Text] [Related]
3. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation.
Bruno RS; Leonard SW; Atkinson J; Montine TJ; Ramakrishnan R; Bray TM; Traber MG
Free Radic Biol Med; 2006 Feb; 40(4):689-97. PubMed ID: 16458200
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers.
Mühlhöfer A; Mrosek S; Schlegel B; Trommer W; Rozario F; Böhles H; Schremmer D; Zoller WG; Biesalski HK
Eur J Clin Nutr; 2004 Aug; 58(8):1151-8. PubMed ID: 15054428
[TBL] [Abstract][Full Text] [Related]
5. Plasma ascorbic acid concentrations in the Republic of Karelia, Russia and in North Karelia, Finland.
Matilainen T; Vartiainen E; Puska P; Alfthan G; Pokusajeva S; Moisejeva N; Uhanov M
Eur J Clin Nutr; 1996 Feb; 50(2):115-20. PubMed ID: 8641247
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
[TBL] [Abstract][Full Text] [Related]
7. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.
Wang S; Berge GE; Hoem NO; Sund RB
Res Vet Sci; 2001 Aug; 71(1):27-32. PubMed ID: 11666144
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
10. Supplemental vitamin C appears to slow racing greyhounds.
Marshall RJ; Scott KC; Hill RC; Lewis DD; Sundstrom D; Jones GL; Harper J
J Nutr; 2002 Jun; 132(6 Suppl 2):1616S-21S. PubMed ID: 12042473
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary fat on oral bioavailability of tepoxalin in dogs.
Homer LM; Clarke CR; Weingarten AJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):287-91. PubMed ID: 15953202
[TBL] [Abstract][Full Text] [Related]
12. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid interference in the measurement of serum biochemical parameters: in vivo and in vitro studies.
Martinello F; da Silva EL
Clin Biochem; 2006 Apr; 39(4):396-403. PubMed ID: 16403487
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of plasma and buffy coat ascorbic acid concentrations in dogs before and after a 24-hour fast.
Lee AH; Spano JS; Swaim SF; McGuire JA; Hughes KS
Am J Vet Res; 1986 Sep; 47(9):2000-3. PubMed ID: 3767105
[TBL] [Abstract][Full Text] [Related]
16. Plasma profiles of lycopene after single oral and intravenous administrations in dogs.
Vertzoni M; Valsami G; Reppas C
J Pharm Pharmacol; 2006 Sep; 58(9):1211-7. PubMed ID: 16945179
[TBL] [Abstract][Full Text] [Related]
17. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
[TBL] [Abstract][Full Text] [Related]
18. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
Duconge J; Miranda-Massari JR; Gonzalez MJ; Jackson JA; Warnock W; Riordan NH
P R Health Sci J; 2008 Mar; 27(1):7-19. PubMed ID: 18450228
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.
Weissinger EM; Nguyen-Khoa T; Fumeron C; Saltiel C; Walden M; Kaiser T; Mischak H; Drüeke TB; Lacour B; Massy ZA
Proteomics; 2006 Feb; 6(3):993-1000. PubMed ID: 16372263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
